Psychopharmacology of Pediatric Anxiety Disorders
| Autor: | Justin W. Mohatt, Alex E. Keller, John T. Walkup |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
chemistry.chemical_classification
medicine.medical_specialty business.industry behavioral disciplines and activities Buspirone First line treatment Pediatric anxiety chemistry mental disorders medicine Anxiety Serotonin Psychopharmacology medicine.symptom Psychiatry business Norepinephrine reuptake medicine.drug Tricyclic |
| Zdroj: | Pediatric Anxiety Disorders ISBN: 9781461465980 |
| Popis: | There are a number of pharmacological approaches used in treating pediatric anxiety disorders. Selective serotonin reuptake inhibitors (SSRIs) are first line treatment, but there are many other treatment options for nonresponders including serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), benzodiazepines (BZDs), buspirone, and other investigational and augmenting agents. This chapter will examine the evidence base for the pharmacological treatment of pediatric obsessive–compulsive disorder (OCD), non-OCD anxiety disorders, and post-traumatic stress disorder (PTSD). Additionally, augmentation strategies and general clinical considerations are presented to aid in formulating an approach to both simple and complex patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|